Related references
Note: Only part of the references are listed.Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis
Shuji Nomoto et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array
Yukiyasu Okamura et al.
CANCER LETTERS (2010)
Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity
Shigeru Kanda et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers
N Sato et al.
GASTROENTEROLOGY (2006)
Association between large-scale genomic homozygosity without chromosomal loss and nonseminomatous germ cell tumor development
YJ Lu et al.
CANCER RESEARCH (2005)
Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies
RA Blaheta et al.
MEDICINAL RESEARCH REVIEWS (2005)
Reelin promoter hypermethylation in schizophrenia
DR Grayson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients:: A preliminary report
HM Abdolmaleky et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid
A Kuendgen et al.
BLOOD (2004)
Reelin and brain development
F Tissir et al.
NATURE REVIEWS NEUROSCIENCE (2003)
DNA methylation and chromatin - unraveling the tangled web
KD Robertson
ONCOGENE (2002)
Molecular pathogenesis of human hepatocellular carcinoma
SS Thorgeirsson et al.
NATURE GENETICS (2002)
Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
RW Johnstone
NATURE REVIEWS DRUG DISCOVERY (2002)
Role of the Reelin signaling pathway in central nervous system development
DS Rice et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis
HC Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
